138 related articles for article (PubMed ID: 4824723)
1. Use of androgens in hematologic disease.
Fried W
Postgrad Med; 1974 May; 55(5):155-61. PubMed ID: 4824723
[No Abstract] [Full Text] [Related]
2. The hemopoietic action of androstanes.
Sanchez-Medal L
Prog Hematol; 1971; 7():111-36. PubMed ID: 4950580
[No Abstract] [Full Text] [Related]
3. Hematologic effects of androgens revisited: an alternative therapy in various hematologic conditions.
Besa EC
Semin Hematol; 1994 Apr; 31(2):134-45. PubMed ID: 8066470
[No Abstract] [Full Text] [Related]
4. [Long-term study on the treatment of bone marrow insufficiencies using androgens].
Najean Y; Dresch C; Laprevotte I
Munch Med Wochenschr; 1971 Jun; 113(25):955-60. PubMed ID: 5108719
[No Abstract] [Full Text] [Related]
5. Physiologic mechanisms and the hematopoietic effects of the androstanes and their derivatives.
Gardner FH; Besa EC
Curr Top Hematol; 1983; 4():123-95. PubMed ID: 6352190
[No Abstract] [Full Text] [Related]
6. Androgens and erythropoiesis.
Shahidi NT
N Engl J Med; 1973 Jul; 289(2):72-80. PubMed ID: 4575719
[No Abstract] [Full Text] [Related]
7. Androgens and erythropoiesis: past and present.
Shahani S; Braga-Basaria M; Maggio M; Basaria S
J Endocrinol Invest; 2009 Sep; 32(8):704-16. PubMed ID: 19494706
[TBL] [Abstract][Full Text] [Related]
8. [Androgens in hematology].
Sanchez-Medal L
Minerva Med; 1971 Jun; 62(51):2598-604. PubMed ID: 5566873
[No Abstract] [Full Text] [Related]
9. Androgen therapy.
Longson D
Practitioner; 1972 Mar; 208(245):338-48. PubMed ID: 4557109
[No Abstract] [Full Text] [Related]
10. [Androstanes in clinical hematology].
Sánchez-Medal L
Rev Clin Esp; 1971 Mar; 120(6):535-8. PubMed ID: 5164711
[No Abstract] [Full Text] [Related]
11. [Androgen treatment of hematologic diseases].
Huang ZL
Zhonghua Nei Ke Za Zhi; 1990 Apr; 29(4):239-42. PubMed ID: 2226054
[No Abstract] [Full Text] [Related]
12. [Do androgens have a therapeutic role in hematology?].
Delwiche F; Velu T
Rev Med Brux; 1985 Apr; 6(4):277-9. PubMed ID: 4039838
[No Abstract] [Full Text] [Related]
13. Erythrokinetics and androgens in bone marrow cancer.
Alexanian R; Alfrey CP
Cancer; 1976 Aug; 38(2):833-40. PubMed ID: 975001
[TBL] [Abstract][Full Text] [Related]
14. [Long-term treatment of medullary insufficiency with androgens].
Najean Y; Dresh C; Laprevotte I
Minerva Med; 1971 Jun; 62(51):2588-97. PubMed ID: 5566872
[No Abstract] [Full Text] [Related]
15. The use and misuse of androgens.
Wilson JD; Griffin JE
Metabolism; 1980 Dec; 29(12):1278-95. PubMed ID: 7005620
[TBL] [Abstract][Full Text] [Related]
16. Anemia of renal failure. A review.
Diaz-Buxo JA; Frohnert PP
Minn Med; 1974 May; 57(5):374-8. PubMed ID: 4824718
[No Abstract] [Full Text] [Related]
17. The role of androgens in the treatment of hematologic disorders.
Ammus SS
Adv Intern Med; 1989; 34():191-208. PubMed ID: 2644756
[No Abstract] [Full Text] [Related]
18. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
Biljanović-Paunović L; Djukanović L; Lezaić V; Stojanović N; Marisavljević D; Pavlović-Kentera V
Eur J Med Res; 1998 Dec; 3(12):564-70. PubMed ID: 9889177
[TBL] [Abstract][Full Text] [Related]
19. [Oluprine and hematopoiesis].
Gebauer D
Dtsch Med J; 1971 Oct; 22(19):618-9. PubMed ID: 5130266
[No Abstract] [Full Text] [Related]
20. [Treatment of bone marrow insufficiencies with androgens].
Najean Y
Therapeutique; 1971 Apr; 47(4):399-402. PubMed ID: 5564054
[No Abstract] [Full Text] [Related]
[Next] [New Search]
